Innovation Pharmaceuticals Valuation
| IPIX Stock | USD 0.0003 0.0001 25.00% |
Innovation Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Innovation Pharmaceuticals from evaluating the firm fundamentals such as Shares Outstanding of 488.32 M, return on asset of -0.32, and Return On Equity of -1.09 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Innovation Pharmaceuticals' price fluctuation is out of control at this time. Calculation of the real value of Innovation Pharmaceuticals is based on 3 months time horizon. Increasing Innovation Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Innovation Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Innovation Pink Sheet. However, Innovation Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.0E-4 | Real 2.88E-4 | Hype 2.8E-4 | Naive 5.06E-4 |
The intrinsic value of Innovation Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Innovation Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Innovation Pharmaceuticals helps investors to forecast how Innovation pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Innovation Pharmaceuticals more accurately as focusing exclusively on Innovation Pharmaceuticals' fundamentals will not take into account other important factors: Innovation Pharmaceuticals Total Value Analysis
Innovation Pharmaceuticals is currently forecasted to have valuation of 7.56 M with market capitalization of 9.52 M, debt of 1.24 M, and cash on hands of 2.97 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Innovation Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.56 M | 9.52 M | 1.24 M | 2.97 M |
Innovation Pharmaceuticals Investor Information
The book value of the company was currently reported as 0.01. The company recorded a loss per share of 0.02. Innovation Pharmaceuticals had not issued any dividends in recent years. Based on the key indicators related to Innovation Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Innovation Pharmaceuticals is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Innovation Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Innovation Pharmaceuticals has an asset utilization ratio of 0.17 percent. This suggests that the Company is making $0.001734 for each dollar of assets. An increasing asset utilization means that Innovation Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Innovation Pharmaceuticals Ownership Allocation
Innovation Pharmaceuticals has a total of 488.32 Million outstanding shares. Innovation Pharmaceuticals retains 10.1 (percent) of its outstanding shares held by insiders and 0.0 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Innovation Pharmaceuticals Profitability Analysis
The company reported the previous year's revenue of 18 K. Net Loss for the year was (7.04 M) with profit before overhead, payroll, taxes, and interest of 18 K.About Innovation Pharmaceuticals Valuation
Our relative valuation model uses a comparative analysis of Innovation Pharmaceuticals. We calculate exposure to Innovation Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Innovation Pharmaceuticals's related companies.Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts. Innovation Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
8 Steps to conduct Innovation Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Innovation Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Innovation Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Innovation Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Innovation Pharmaceuticals' revenue streams: Identify Innovation Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Innovation Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Innovation Pharmaceuticals' growth potential: Evaluate Innovation Pharmaceuticals' management, business model, and growth potential.
- Determine Innovation Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Innovation Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Innovation Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 472.2 M | |
| Retained Earnings | -122.2 M | |
| Shares Float | 439.3 M |
Additional Tools for Innovation Pink Sheet Analysis
When running Innovation Pharmaceuticals' price analysis, check to measure Innovation Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation Pharmaceuticals is operating at the current time. Most of Innovation Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Innovation Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation Pharmaceuticals' price. Additionally, you may evaluate how the addition of Innovation Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.